FX-322 in Adults With Age-Related Sensorineural Hearing Loss
NCT04601909
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Presbycusis
Hearing Loss, Sensorineural
Noise Induced Hearing Loss
Sudden Hearing Loss
Interventions
DRUG:
FX-322
OTHER:
placebo
Sponsor
Frequency Therapeutics